Thymosin beta4 derivative and itsuse
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- BEIJING NORTHLAND BIOTECH
- Publication Date
- 2007-03-28
Smart Images
Figure 1 Figure 2
Abstract
Description
1. Technical field
[0001] The present invention belongs to the field of production of protein drug derivatives. By modifying the natural protein thymosin β4 (Tβ4), a derivative of Tβ4, Gly-Tβ4, was obtained. Experiments have proved that the derivative plays a very important role in the repair process of damaged tissues, and is expected to be developed as a new drug for the benefit of human beings. 2. Background technology
[0002] The immune system is the body's defense system. The main cells involved in the immune response are T lymphocytes, B lymphocytes and macrophages. The thymus is the central immune organ for the development and differentiation of T lymphocytes. Thymus factors (or hormones) secreted by the thymus are a series of essential substances required for the development and differentiation of T lymphocytes, among which thymosin β4 (Tβ4) is a major thymus factor whose structure and function have been clarified. Thymosin-beta 4 enhanced embryonic and postnata...